To Upload your aptamers in our database
For LOGIN
# | Aptamer Name | Aptamer Target (General) | Aptamer Target (Specific) | Length | Affinity | Buffer | GC Content | Sequence | Reference |
---|---|---|---|---|---|---|---|---|---|
191 | Human Umbilical Vein Endothelial Cells | Cells | Human Umbilical Vein Endothelial Cells | 5 | N/A nM | N/A | NH2-CGKRK-COOCOOH | Agemy et al. "Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma." PNAS, doi: 10.1073/pnas.1114518108. | |
192 | Trypsin | Protein | Trypsin | 6 | N/A pM | 89% Inhibition Buffer (0.1M Tris-HCl, 0.025M CaCl2 (pH 7.8)) | NH2-TTKIFT-COOCOOH | Yokobayashi et al. "Directed evolution of trypsin inhibiting peptides using a genetic algorithm." Journal of the Chemical Society, 1(1996): 2435-2437 | |
193 | Liver-Specific Ligands (236) | Tissue | Liver-Specific Ligands | 7 | n/a nM | Selection Buffer (PBS, 1 M NaCl, and 2% Triton X-100) Wash Buffers (0.1% Sodium Borohydride, 0.1 M Phosphate Buffer) (PBS, 5% BSA, 0.1% cold water fish gelatin, and 5% normal goat serum in PBS) Incubation Buffer (PBS and 1.1% BSA-C) | NH2-QRVLVKK-COOCOOH | Ludtke et al. "In Vivo Selection and Validation of Liver-Specific Ligands Using a New T7 Phage Peptide Display System." Drug Delivery, 14(2007): 357-369. | |
194 | Renal Tissue (Glomerulus and Intertubular tissue) | Tissue | Glomerular vessels and renal intertubular tissue | 7 | N/A nM | In vivo mice. | NH2-CLPVASC-COOCOOH | Pasqualini and Ruoslahti. "Organ targeting in vivo using phage display peptide libraries." Letters to Nature, 380(1996):364-366. | |
195 | VEGF-KDR | Tissue | VEGF-KDR | 7 | ~80 µM | Binding Buffer: DMEM supplemented with 20 mM HEPES (pH 7.4) and 2 mg/mL gelatin | NH2-ATWLPPR-COOCOOH | Binetruy-Tournaire et al. "Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis." The EMBO Journal, 19(2000): 1525-1533 | |
196 | Mouse Placenta | Tissue | Neonatal Fc Receptor | 7 | N/A nM | In vivo in pregnant mice. | NH2-TPKTSVT-COOCOOH | Kolonin et al. "Teratogenicity induced by targeting a placental immunoglobulin transporter." PNAS, 99(2002): 13055-13060. | |
197 | Nestin Protein expressed in Brain Tumors (clone 17) | Protein | Nestin Protein expressed in Brain Tumors | 7 | N/A nM | Binding Buffer (PBS containing 1% BSA) Wash Buffer (PBS with 0.05% Tween 20), 4°C | NH2-AQTLAPS-COOCOOH | Beck et al. "Indentification of a peptide that interacts with Nestin protein expressed in brain cancer cells." Biomaterials, 32(2011): 8518-8528 | |
198 | ErbB2 Tyrosine Kinase Receptor (Ph7-2) | Protein | ErbB2 Tyrosine Kinase Receptor | 7 | N/A nM | N/A | 5'-LTVSPWY-3' | Shadidi and Sioud. "Identification of Novel Peptides for the Specific Delivery of Therapeutics into Cancer Cells." The FASEB Journal, 2, (2003): 256-8. | |
199 | Human Transferrin Receptor (T7) | Protein | Human Transferrin Receptor (hTfR) | 7 | N/A nM | Serum-free Opti-MEM. | 5'-HAIYPRH-3' | J. H. Lee et al. Receptor mediated uptake of peptides that bind the human transferrin receptor. Eur. J. Biochm. 268(2001): 2004-2012. | |
200 | VEGF-Stimulated HUVECs | Tissue | VEGF-Stimulated Human Umbilical Vein Endothelial Cells (HUVECs) | 8 | N/A nM | In vivo mice. | NH2-PVVLFPLH-COOCOOH | Asai et al. "Isolation of a Novel Peptide Homing to Tumor-Derived Neovasculature That Suppresses Tumor Growth." Biological Pharmaceutical Bulletin, 25(2002): 904-906. |